SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Gastroenterology Consultation — Charles Darwin — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.
| Patient | Charles Darwin |
|---|
| Date of birth | 1809-02-12 |
|---|
| Identifiers | MRN HR-NI003-SYN-TD; SSN (made up) 000-03-2967 |
|---|
| Document date | 1849-04-14 |
|---|
| Author | Mei-Ling Zhou, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Recurrent stereotyped episodes of nausea and vomiting for more than a year in a 40-year-old man, about every one to three weeks and almost weekly this winter. Please advise whether this is cyclic vomiting syndrome, whether the work-up is complete, and on prophylaxis, abortive treatment, and an emergency plan. [S]
Urgency: Routine, within six weeks, on the same day as his results visit. [S]
Questions for the consultant:
- Do his episodes meet the Rome IV criteria for cyclic vomiting syndrome, and is anything in the history against it?
- Is the work-up complete, or are further tests needed (for example a gastric emptying study or brain imaging)?
- Do you advise prophylaxis, and if so which medicine, at what dose, and with what monitoring?
- What abortive treatment should he take at the prodrome?
- What should an emergency department do when an episode does not settle?
- How should his anxiety about episodes and his triggers be addressed, and how often should he be followed?
History of Present Illness
Mr. Darwin, a 40-year-old writer and naturalist, is seen at the request of Dr. Ashworth for more than a year of stereotyped vomiting episodes. His diary shows three episodes in the six weeks since his first visit, each 18 to 30 hours, after a prodrome of nausea, sweating, trembling, palpitations, and a swimming head lasting half an hour to an hour. Vomiting is frequent at the peak, then he sleeps. Between episodes he does not vomit, though he has wind and tires by the afternoon. Episodes follow social evenings, travel, short nights, and missed meals. He has no headaches with or between episodes, no dizziness on standing, and no weight loss, nocturnal pain, or blood. He has never used cannabis, by any route, and does not bathe compulsively. He drinks little alcohol and takes no medicines. He worries about being taken ill in company and has begun to avoid gatherings. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Charles Darwin was born on February 12, 1809, in Shrewsbury, Shropshire, England. [D]
- While waiting at Plymouth to sail on the Beagle in late 1831, Darwin was troubled with palpitations and pain about the heart, and consulted no doctor for fear of being judged unfit for the voyage. [D]
- In September 1837 he had palpitations and, on his doctors' advice, went to the country to recover. [D]
- Darwin first mentioned periodical vomiting in a letter to W. D. Fox in June 1840. [D]
- In February 1849 he described incessant vomiting to Richard Owen, and in March 1849 he wrote that he had been bad all winter, with dreadful vomiting every week, that his hands trembled, and that his head was often swimming. [D]
- Over his adult life he had gastrointestinal distress, including vomiting, retching, and bowel irregularity, with headaches, fatigue, trembling, faintness, dizziness, and skin problems including eczema. [D]
- Cyclic vomiting syndrome, perhaps from a mitochondrial DNA disorder, has been proposed as the cause of his illness. [R]
- Chagas disease, contracted during the Beagle voyage, has been proposed as the cause of his illness. [R]
- Systemic lactose intolerance has been proposed as the cause of his illness. [R]
- Panic disorder with agoraphobia has been proposed as the explanation of his illness and secluded life. [R]
- Other proposed explanations include hyperventilation, neurasthenia, hypoglycemia, other allergies, Crohn's disease, Helicobacter pylori infection, systemic lupus, Meniere's disease, and psychological or psychosomatic causes. [R]
5 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Amitriptyline 25 mg oral tablet, one tablet at bedtime | One tablet by mouth at bedtime | Oral route | 1849-04-14 to 1849-04-28 | completed | S |
| Sumatriptan 20 mg nasal spray, one spray at the first sign of an episode | One spray in one nostril at the start of the prodrome; may repeat once after 2 hours; no more than 2 sprays a day or 6 a week | Nasal route | 1849-04-14 | active | S |
| Ondansetron 8 mg orally disintegrating tablet at the first sign of an episode | Dissolve one tablet on the tongue at the start of the prodrome, then every 8 hours as needed during an episode | Oral route | 1849-04-14 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Cyclic vomiting syndrome, moderate to severe, meeting Rome IV criteria after a normal work-up; provisional clinical diagnosis | active | provisional |
R11.15 | S — Synthetic provisional diagnosis at the gastroenterology consultation, anchored to his documented episodic vomiting. It is clinical, with no confirmatory test, and does not confirm any historical theory. |
| Recurrent episodes of nausea and vomiting over more than a year, with prodromal trembling, palpitations, and dizziness, and flatulence and fatigue between episodes; cause under evaluation | resolved | confirmed |
R11.2 | S — Synthetic presenting concern at the index visit, superseded by the provisional diagnosis at the six-week visit; the episodic vomiting is documented (D). |
Physical Exam
Vital signs recorded on 1849-04-14; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| General | Well between episodes; weight 71.4 kg |
| Cardiovascular | Regular rhythm at 76 per minute; blood pressure 116/72 mmHg, with no drop on standing |
| Abdomen | Soft and non-tender; no distension, masses, organ enlargement, or succussion splash; normal bowel sounds |
| Neurological | Cranial nerves and gait normal; no nystagmus |
Assessment
- Cyclic vomiting syndrome, provisional (R11.15). He meets the Rome IV criteria: stereotyped episodes of acute-onset vomiting lasting less than a week, well over three in the past year and two in the past six months, at least a week apart, with no vomiting between episodes, and onset more than three months ago. The prodrome, the triggers, and relief with sleep in a dark room are typical. Cannabinoid hyperemesis syndrome is excluded by his history. With episodes every one to three weeks that stop his work, it is moderate to severe. The diagnosis is clinical, with no confirmatory test, so it is recorded as provisional and should be revisited if the pattern changes. [S]
- Work-up. Complete. The blood and urine tests, CT enterography, and upper endoscopy exclude obstruction, malrotation, mucosal disease, pancreatitis, celiac disease, and thyroid, adrenal, and metabolic causes. A gastric emptying study is not needed, as he has no symptoms of gastroparesis between episodes, and brain imaging is not needed without headache or neurological signs. Repeat testing is not advised unless an episode is atypical. [S]
- Prophylaxis. A tricyclic is first line for moderate-to-severe disease. Amitriptyline at about 1 to 1.5 mg/kg is the usual effective dose, which for him is 75 to 100 mg at bedtime. His baseline QTc of 412 ms allows it. Coenzyme Q10 and riboflavin are conditional options that can be added later if the response is partial; topiramate or aprepitant are alternatives if amitriptyline fails or is not tolerated. [S]
- Abortive treatment. Nasal sumatriptan with an ondansetron dissolving tablet, taken together within the first 30 to 45 minutes of the prodrome, works best. He has no heart disease, uncontrolled hypertension, or stroke that would rule out a triptan. The serotonin syndrome risk with amitriptyline is low at these doses, and he was told its warning signs. [S]
- Anxiety and triggers. Mild anxiety (GAD-7 8) centered on episodes, without low mood. Anxiety and stress both trigger episodes and follow from them, so relaxation training and cognitive behavioral therapy are worthwhile alongside medicine. No anxiety disorder is diagnosed. [S]
Data reviewed: Dr. Ashworth's evaluation six weeks ago, including the diary format, blood count, metabolic and liver panels, lipase, TSH, morning cortisol, celiac serology, urinalysis, the ECG (QTc 412 ms), GAD-7 8, and PHQ-9 6; the CT enterography report from four weeks ago (normal small and large bowel, no obstruction, malrotation, or stricture, normal solid organs); the upper endoscopy report and duodenal biopsy result from two weeks ago (normal); and today's vital signs. [S]
Plan of Treatment
- Amitriptyline 25 mg at bedtime, raised by 25 mg every two weeks to 75 mg; ECG at about 50 mg and at 75 mg, keeping the QTc below 450 ms; judge the response after three months at the target dose and continue for at least a year if it helps. [S]
- Sumatriptan 20 mg nasal spray with ondansetron 8 mg dissolving tablet at the first sign of the prodrome; the spray may be repeated once after 2 hours, no more than 6 sprays a week. [S]
- Emergency department letter: intravenous fluids with dextrose, intravenous ondansetron, lorazepam 1 to 2 mg if needed, a dark quiet room, a check of electrolytes and lipase, and opioids used sparingly. [S]
- Trigger plan: regular small meals, regular sleep, planning around travel and social events, and early treatment of infections; continue to avoid cannabis. [S]
- Relaxation breathing now, and cognitive behavioral therapy if he is willing. [S]
- Keep the symptom diary and bring it to each visit. [S]
- No further tests now; no gastric emptying study or brain imaging. [S]
- Primary care review at about three months and six months; gastroenterology review if there is no response after three months at the target dose, or if the pattern changes. [S]
- Discussed with Dr. Ashworth, who sees him the same day. The provisional nature of the diagnosis, the reason for prophylaxis, and the abortive and emergency plans were explained to Mr. Darwin, who asked for the plan in writing and agreed to it. [S]
- Follow-up: Gastroenterology review as needed: if there is no response after three months at 75 mg, if episodes change in character, or if side effects prevent the dose from being reached. [S]